Shili Ning

1.5k total citations · 1 hit paper
26 papers, 1.2k citations indexed

About

Shili Ning is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Shili Ning has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Shili Ning's work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (4 papers) and Autophagy in Disease and Therapy (3 papers). Shili Ning is often cited by papers focused on MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (4 papers) and Autophagy in Disease and Therapy (3 papers). Shili Ning collaborates with scholars based in China. Shili Ning's co-authors include Xiaofeng Tian, Jihong Yao, Dongcheng Feng, Yan Zhao, Deshun Liu, Ruimin Sun, Feng Zhang, Li Yang, Zhanyu Wang and Guangzhi Wang and has published in prestigious journals such as Free Radical Biology and Medicine, Cell Death and Differentiation and Cellular and Molecular Life Sciences.

In The Last Decade

Shili Ning

22 papers receiving 1.2k citations

Hit Papers

Ischemia-induced ACSL4 activation contributes to ferropto... 2019 2026 2021 2023 2019 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shili Ning China 13 681 543 532 140 124 26 1.2k
Fei Deng China 20 684 1.0× 408 0.8× 385 0.7× 152 1.1× 141 1.1× 64 1.4k
Dongcheng Feng China 14 795 1.2× 527 1.0× 625 1.2× 136 1.0× 238 1.9× 22 1.4k
Zhanyu Wang China 10 611 0.9× 502 0.9× 434 0.8× 67 0.5× 109 0.9× 14 1.0k
Chongxiu Yue China 6 553 0.8× 662 1.2× 485 0.9× 58 0.4× 51 0.4× 7 1.0k
Mehdi A. Fini United States 19 559 0.8× 527 1.0× 298 0.6× 171 1.2× 205 1.7× 30 1.5k
Yetong Feng China 12 545 0.8× 514 0.9× 392 0.7× 72 0.5× 74 0.6× 28 964
Zhenzhu Sun China 15 523 0.8× 225 0.4× 231 0.4× 82 0.6× 98 0.8× 39 988
Fanglin Niu China 11 425 0.6× 326 0.6× 305 0.6× 52 0.4× 61 0.5× 38 882
He-He Hu China 11 554 0.8× 273 0.5× 128 0.2× 156 1.1× 120 1.0× 14 1.3k

Countries citing papers authored by Shili Ning

Since Specialization
Citations

This map shows the geographic impact of Shili Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shili Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shili Ning more than expected).

Fields of papers citing papers by Shili Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shili Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shili Ning. The network helps show where Shili Ning may publish in the future.

Co-authorship network of co-authors of Shili Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Shili Ning. A scholar is included among the top collaborators of Shili Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shili Ning. Shili Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Shili, Ping Zhong, Yan Zhao, et al.. (2025). USP5-induced deubiquitination of P4HB alleviates ER stress-mediated apoptosis in intestinal ischemia/reperfusion. Cellular and Molecular Life Sciences. 82(1). 231–231.
2.
Liu, Deshun, Yan Zhao, Zhecheng Wang, et al.. (2024). HRD1-induced TMEM2 ubiquitination promotes ER stress-mediated apoptosis through a non-canonical pathway in intestinal ischemia/reperfusion. Cell Death and Disease. 15(2). 154–154. 5 indexed citations
3.
Liu, Deshun, Zhecheng Wang, Guangzhi Wang, et al.. (2024). A novel protein encoded by circARHGAP12 attenuates DNA damage and apoptosis by regulating MDC1 in intestinal ischemia/reperfusion injury. International Journal of Biological Macromolecules. 286. 138374–138374.
4.
Ning, Shili, Yuzhuo Chen, Guangzhi Wang, et al.. (2022). Ring finger protein 128 promotes, rather than inhibits, colorectal cancer progression by regulating the Hippo signaling pathway. Frontiers in Oncology. 12. 1031160–1031160. 7 indexed citations
5.
Chen, Zhao, Zhecheng Wang, Deshun Liu, et al.. (2022). Critical role of caveolin-1 in intestinal ischemia reperfusion by inhibiting protein kinase C βII. Free Radical Biology and Medicine. 194. 62–70. 5 indexed citations
7.
Zhao, Zhengdong, Yaqing Liu, Xingming Liu, et al.. (2022). Bioinformatics analysis reveals the clinical significance of GIPC2/GPD1L for colorectal cancer using TCGA database. Translational Cancer Research. 11(4). 761–771. 6 indexed citations
8.
Li, Wenxin, Zhiqiang Hao, Hai Shang, et al.. (2021). Olaparib effectively treats local recurrence of extrahepatic cholangiocarcinoma in a patient harboring a BRCA2-inactivating mutation: a case report. Annals of Translational Medicine. 9(18). 1487–1487. 8 indexed citations
9.
Wang, Yue, Yan Zhao, Zhecheng Wang, et al.. (2021). Peroxiredoxin 3 Inhibits Acetaminophen-Induced Liver Pyroptosis Through the Regulation of Mitochondrial ROS. Frontiers in Immunology. 12. 65 indexed citations
10.
Feng, Dongcheng, Zhecheng Wang, Yan Zhao, et al.. (2020). circ-PRKCB acts as a ceRNA to regulate p66Shc-mediated oxidative stress in intestinal ischemia/reperfusion. Theranostics. 10(23). 10680–10696. 22 indexed citations
11.
Wang, Guangzhi, et al.. (2020). Haemorrhagic retroperitoneal paraganglioma initially manifesting as acute abdomen: a rare case report and literature review. BMC Surgery. 20(1). 304–304. 4 indexed citations
13.
Yang, Li, Dongcheng Feng, Zhanyu Wang, et al.. (2019). Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. Cell Death and Differentiation. 26(11). 2284–2299. 687 indexed citations breakdown →
15.
Li, Zhenlu, Guangzhi Wang, Dongcheng Feng, et al.. (2018). Targeting the miR-665-3p-ATG4B-autophagy axis relieves inflammation and apoptosis in intestinal ischemia/reperfusion. Cell Death and Disease. 9(5). 483–483. 78 indexed citations
16.
Ning, Shili, et al.. (2018). CDC27 Facilitates Gastric Cancer Cell Proliferation, Invasion and Metastasis via Twist-Induced Epithelial-Mesenchymal Transition. Cellular Physiology and Biochemistry. 50(2). 501–511. 26 indexed citations
17.
Zhou, Wei, Jihong Yao, Guangzhi Wang, et al.. (2017). PKCζ phosphorylates TRAF2 to protect against intestinal ischemia–reperfusion–induced injury. Cell Death and Disease. 8(7). e2935–e2935. 15 indexed citations
18.
Zu, Guo, Jihong Yao, Shili Ning, et al.. (2016). Nurr1 promotes intestinal regeneration after ischemia/reperfusion injury by inhibiting the expression of p21 (Waf1/Cip1). Journal of Molecular Medicine. 95(1). 83–95. 26 indexed citations
19.
Zhang, Feng, Yan Hu, Xiaohan Zhai, et al.. (2014). Icariin protects against intestinal ischemia–reperfusion injury. Journal of Surgical Research. 194(1). 127–138. 29 indexed citations
20.
Wang, Guangzhi, Zhao Chen, Feng Zhang, et al.. (2014). Blockade of PKCβ protects against remote organ injury induced by intestinal ischemia and reperfusion via a p66shc-mediated mitochondrial apoptotic pathway. APOPTOSIS. 19(9). 1342–1353. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026